Day: October 16, 2023

Bombardier Ramps Up Second Test Phase of EcoJet Research Project, Sees 18-Foot-Wide Prototype Flying

Bombardier’s EcoJet family of Blended Wing Body (BWB) test vehicles Bombardier solidifies its leadership position in sustainable aviation and continues its industry-defining work on the EcoJet research project by ramping up the second phase of testing As part of this new stage of the EcoJet research project, Bombardier is flying an 18-foot-wide test vehicle designed […]

Official Statement: Saurabh Chandrakar Clarifies Misinformation Surrounding Wedding Expenses and Other Allegations

Mr. Saurabh Chandrakar Photo DELHI, India, Oct. 16, 2023 (GLOBE NEWSWIRE) — In light of recent media reports surrounding the Mahadev App case, Mr. Saurabh Chandrakar, an entrepreneur hailing from Bhilai, Chhattisgarh, finds it imperative to address the glaring misinformation and unfounded accusations that have surfaced. As a dedicated businessman with an unblemished record, Mr. […]

Crurated Announces Exclusive Availability of Vintage Collection Wines from Domaine Robert Groffier for Both Private Buyers and Restaurants Globally

Crurated Announces Exclusive Availability of Vintage Collection Wines from Domaine Robert Groffier for Both Private Buyers and Restaurants Globally LONDON, Oct. 16, 2023 (GLOBE NEWSWIRE) — Crurated, the London-based membership wine community designed to connect connoisseurs with world-class producers, announces the availability of vintage collection wines from Domaine Robert Groffier. The collection will be sold […]

Fortinet Expands Its Global SASE Points-of-Presence with Google Cloud

Google Cloud Network’s Global Network Edge Locations Will Expand Fortinet’s POP Coverage for Universal SASE Customers SUNNYVALE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — News Summary Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced the expansion of its SASE Points-of-Presence (POPs) to new locations through a partnership […]

Lacrosse to return to the Olympic Games in 2028

MUMBAI, India, Oct. 16, 2023 (GLOBE NEWSWIRE) — World Lacrosse’s decades-long vision to return the sport to the Olympic stage has been realized, with the International Olympic Committee approving lacrosse’s inclusion in the 2028 Olympic Games in Los Angeles. The approving vote today by the IOC Session – which includes 99 international sport leaders – […]

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial demonstrating statistically significant and clinically meaningful benefit of a neoadjuvant therapy in fully resectable locally advanced melanoma patients Nidlegy™ is the first immunocytokine product to show positive data in […]

Atos Cloud Computing, the first authorized foreign-funded company to operate data centre and cloud computing services nationwide in China, renews its Value-Added Telecommunication Services licenses

Wuhan, China – October 16, 2023 – Atos has renewed its Value-Added Telecommunication Services licenses (VATS licenses) in China, enabling it to run world class digital services and data centers across the country. Atos Cloud Computing has retained the licenses since 2019, being the first authorized foreign-funded company to operate cloud computing VATS regulated activities […]

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa (HS) Maintenance treatment with sonelokimab dosed every 4 weeks (Q4W), demonstrated that 57% of patients achieved HiSCR75 at week 24, increasing the landmark week 12 responses (primary endpoint) […]